Q: What is Complera?

Complera contains three active ingredients: emtricitabine , rilpivirine , and tenofovir disoproxil fumarate . These components are types of antiretroviral drugs that work together to manage the virus. The medication functions by interfering with the enzymes the virus needs to multiply. This action helps to reduce the viral presence in the body and allows the immune system to work better.

Q: What is Complera used for?

Complera is used to treat HIV-1 infection .

Q: How does Complera work?

Mechanism of Action Complera is a combination of three antiretroviral medications: emtricitabine, rilpivirine, and tenofovir disoproxil fumarate. These drugs work together to interfere with the replication cycle of the human immunodeficiency virus (HIV-1). The virus requires a specific enzyme called reverse transcriptase to convert its viral RNA into DNA, a necessary step for the virus to multiply and infect new cells. The components of Complera block this enzyme in two distinct ways: NNRTI Action: Rilpivirine is a non-nucleoside reverse transcriptase inhibitor. It binds directly to the reverse transcriptase enzyme and physically prevents it from working. NRTI Action: Emtricitabine and tenofovir are nucleoside/nucleotide reverse transcriptase inhibitors. They mimic the natural building blocks the virus uses to create DNA. When the virus incorporates these decoy blocks into its DNA chain, the chain is terminated, and the virus cannot complete its replication process. By inhibiting the reverse transcriptase enzyme, Complera reduces the amount of HIV in the bloodstream, which is referred to as the viral load. Lowering the viral load helps protect the immune system and may increase the number of CD4 cells, which are white blood cells vital for fighting off other infections. While this treatment helps manage the virus, it is not a cure for HIV or AIDS.

Q: What are the active ingredients in Complera?

The active ingredients in Complera are rilpivirine , emtricitabine , and tenofovir disoproxil .

Q: What are the side effects of Complera?

Common side effects of Complera may include: Nausea Dizziness Abnormal dreams and others. Always consult with a healthcare professional about potential side effects.

Q: What drug class is Complera?

Complera belongs to the antiretroviral combination drug class .

Q: What is the dosage of Complera and how do I take it?

How to Take Complera Complera should be taken exactly as prescribed by a healthcare provider. It is typically taken once per day at the same time each day to maintain a steady level of medicine in the body. Food Requirements It is essential to take this medication with a meal. Taking it with a meal is necessary for the body to absorb the medicine correctly. A protein drink or a light snack is not considered a substitute for a full meal and may not provide enough absorption. Missed Doses If a dose is missed, it should be taken with a meal as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped and the regular dosing schedule should be resumed. Do not take two doses at the same time to make up for a missed one. General Administration Swallow the tablet whole with water. Do not stop taking the medication or change the dose without consulting a healthcare provider, as this can cause the virus to become more difficult to treat. Ensure a steady supply of the medication to avoid running out, as missing doses can lead to drug resistance.

Q: Is Complera safe during pregnancy and breastfeeding?

Pregnancy Data regarding the use of Complera during pregnancy are limited. While animal studies on the individual components of the drug have not shown a high risk of birth defects, human data are insufficient to confirm safety. It is important for pregnant individuals to discuss the risks and benefits of continuing HIV treatment with their healthcare provider. Research indicates that levels of rilpivirine, one of the components of Complera, may be lower during the second and third trimesters of pregnancy. Because of this, healthcare providers may monitor viral loads more closely to ensure the virus remains suppressed. If the medication is not effectively controlling the virus, a change in treatment may be required. There is an Antiviral Pregnancy Registry that collects data on pregnancy outcomes in individuals exposed to HIV medications. This registry helps healthcare professionals better understand the safety of these drugs during pregnancy. Breastfeeding In the United States and other regions where safe infant formula is available, health experts recommend that individuals with HIV avoid breastfeeding. This recommendation is intended to prevent the transmission of HIV to the infant through breast milk. Furthermore, some components of Complera are known to pass into human breast milk. The effects of these drugs on a nursing infant are not fully understood, and there is a risk that the infant could develop resistance to HIV medications if they are exposed to low levels of the drug through milk. Discussing safe feeding alternatives with a healthcare provider is recommended.

Q: What forms and strengths does Complera come in?

Available Forms Complera is supplied as a film-coated tablet. This medication is a fixed-dose combination product intended for oral use, containing active ingredients combined into a pill. Oral tablet

Q: What is the FDA approval status of Complera?

FDA Approval and Indications Complera was approved by the U.S. Food and Drug Administration (FDA) in 2011. It is a fixed-dose combination tablet indicated as a complete regimen for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 35 kg. It is specifically used for patients who have not previously received antiretroviral therapy and have HIV-1 RNA levels of 100,000 copies/mL or less, or to replace a stable regimen in patients who are virologically suppressed. Boxed Warning The medication carries a boxed warning regarding the risk of severe acute exacerbations of hepatitis B (HBV). Patients co-infected with both HIV-1 and HBV have reported significant worsening of hepatitis B after stopping treatment with medications containing emtricitabine or tenofovir disoproxil fumarate, which are components of Complera. Close monitoring of liver function is required for these patients if the drug is discontinued. Regulatory Status Complera is classified as a prescription-only medication. While it does not require a Risk Evaluation and Mitigation Strategy (REMS), the FDA requires that a medication guide be provided to patients to communicate important safety information regarding its use and potential risks.

Question 1

What is Complera?

Accepted Answer

Complera contains three active ingredients: emtricitabine, rilpivirine, and tenofovir disoproxil fumarate. These components are types of antiretroviral drugs that work together to manage the virus.

The medication functions by interfering with the enzymes the virus needs to multiply. This action helps to reduce the viral presence in the body and allows the immune system to work better.

Question 2

What is Complera used for?

Accepted Answer

Complera is used to treat HIV-1 infection.

Question 3

How does Complera work?

Accepted Answer

Mechanism of Action

Complera is a combination of three antiretroviral medications: emtricitabine, rilpivirine, and tenofovir disoproxil fumarate. These drugs work together to interfere with the replication cycle of the human immunodeficiency virus (HIV-1).

The virus requires a specific enzyme called reverse transcriptase to convert its viral RNA into DNA, a necessary step for the virus to multiply and infect new cells. The components of Complera block this enzyme in two distinct ways:

NNRTI Action: Rilpivirine is a non-nucleoside reverse transcriptase inhibitor. It binds directly to the reverse transcriptase enzyme and physically prevents it from working.
NRTI Action: Emtricitabine and tenofovir are nucleoside/nucleotide reverse transcriptase inhibitors. They mimic the natural building blocks the virus uses to create DNA. When the virus incorporates these decoy blocks into its DNA chain, the chain is terminated, and the virus cannot complete its replication process.

By inhibiting the reverse transcriptase enzyme, Complera reduces the amount of HIV in the bloodstream, which is referred to as the viral load. Lowering the viral load helps protect the immune system and may increase the number of CD4 cells, which are white blood cells vital for fighting off other infections. While this treatment helps manage the virus, it is not a cure for HIV or AIDS.

Question 4

What are the active ingredients in Complera?

Accepted Answer

The active ingredients in Complera are rilpivirine, emtricitabine, and tenofovir disoproxil.

Question 5

What are the side effects of Complera?

Accepted Answer

Common side effects of Complera may include:

Nausea
Dizziness
Abnormal dreams
and others.

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Complera?

Accepted Answer

Complera belongs to the antiretroviral combination drug class.

Question 7

What is the dosage of Complera and how do I take it?

Accepted Answer

How to Take Complera

Complera should be taken exactly as prescribed by a healthcare provider. It is typically taken once per day at the same time each day to maintain a steady level of medicine in the body.

Food Requirements

It is essential to take this medication with a meal. Taking it with a meal is necessary for the body to absorb the medicine correctly. A protein drink or a light snack is not considered a substitute for a full meal and may not provide enough absorption.

Missed Doses

If a dose is missed, it should be taken with a meal as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped and the regular dosing schedule should be resumed. Do not take two doses at the same time to make up for a missed one.

General Administration

Swallow the tablet whole with water.
Do not stop taking the medication or change the dose without consulting a healthcare provider, as this can cause the virus to become more difficult to treat.
Ensure a steady supply of the medication to avoid running out, as missing doses can lead to drug resistance.

Question 8

Is Complera safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Data regarding the use of Complera during pregnancy are limited. While animal studies on the individual components of the drug have not shown a high risk of birth defects, human data are insufficient to confirm safety. It is important for pregnant individuals to discuss the risks and benefits of continuing HIV treatment with their healthcare provider.

Research indicates that levels of rilpivirine, one of the components of Complera, may be lower during the second and third trimesters of pregnancy. Because of this, healthcare providers may monitor viral loads more closely to ensure the virus remains suppressed. If the medication is not effectively controlling the virus, a change in treatment may be required.

There is an Antiviral Pregnancy Registry that collects data on pregnancy outcomes in individuals exposed to HIV medications. This registry helps healthcare professionals better understand the safety of these drugs during pregnancy.

Breastfeeding

In the United States and other regions where safe infant formula is available, health experts recommend that individuals with HIV avoid breastfeeding. This recommendation is intended to prevent the transmission of HIV to the infant through breast milk.

Furthermore, some components of Complera are known to pass into human breast milk. The effects of these drugs on a nursing infant are not fully understood, and there is a risk that the infant could develop resistance to HIV medications if they are exposed to low levels of the drug through milk. Discussing safe feeding alternatives with a healthcare provider is recommended.

Question 9

What forms and strengths does Complera come in?

Accepted Answer

Available Forms

Complera is supplied as a film-coated tablet. This medication is a fixed-dose combination product intended for oral use, containing active ingredients combined into a pill.

Oral tablet

Question 10

What is the FDA approval status of Complera?

Accepted Answer

FDA Approval and Indications

Complera was approved by the U.S. Food and Drug Administration (FDA) in 2011. It is a fixed-dose combination tablet indicated as a complete regimen for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 35 kg. It is specifically used for patients who have not previously received antiretroviral therapy and have HIV-1 RNA levels of 100,000 copies/mL or less, or to replace a stable regimen in patients who are virologically suppressed.

Boxed Warning

The medication carries a boxed warning regarding the risk of severe acute exacerbations of hepatitis B (HBV). Patients co-infected with both HIV-1 and HBV have reported significant worsening of hepatitis B after stopping treatment with medications containing emtricitabine or tenofovir disoproxil fumarate, which are components of Complera. Close monitoring of liver function is required for these patients if the drug is discontinued.

Regulatory Status

Complera is classified as a prescription-only medication. While it does not require a Risk Evaluation and Mitigation Strategy (REMS), the FDA requires that a medication guide be provided to patients to communicate important safety information regarding its use and potential risks.

Question 11

What should I know about Complera and cost?

Accepted Answer

Insurance Coverage

Complera is a brand-name prescription medication. Most commercial insurance plans, Medicare Part D, and Medicaid provide coverage for this drug. However, the specific out-of-pocket cost will vary based on your plan's formulary, which determines the drug's tier and your required copayment or coinsurance. Some insurance providers may require prior authorization before they agree to cover the medication.

Factors Affecting Price

Several variables can influence the final price you pay for Complera:

Pharmacy Selection: Prices can differ between retail pharmacies, mail-order services, and specialty pharmacies.
Deductibles: If your insurance plan has a deductible, you may need to pay the full cost of the medication until that limit is reached.
Generic Availability: Complera is a combination of three specific medications. While some individual components may be available as generics, the specific combination tablet is typically sold as a brand-name product, which generally costs more than generic alternatives.

Financial Assistance

For individuals who have difficulty affording their medication, there are several options to explore:

Manufacturer Assistance: The pharmaceutical company that makes Complera may offer patient assistance programs or co-pay savings cards for eligible patients with commercial insurance.
State Assistance Programs: The AIDS Drug Assistance Program (ADAP) is a state-run program that helps provide HIV medications to people with limited or no insurance coverage.
Non-Profit Organizations: Certain foundations may provide grants or financial aid to help cover the costs of chronic disease medications.

Complera

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Complera

Hospitals.net Disclosure